Rigetti Computing is one of the few publicly traded pure-play quantum computing companies, designing and manufacturing superconducting quantum processors using its proprietary Fab-1 fabrication facility. The company reported Q1 2026 revenue of $4.4 million, a striking 199% year-over-year increase that marked a meaningful inflection after four quarters of flat ~$1.8M revenue. While still modest in absolute terms, this acceleration signals early traction in its QPU-as-a-service and hardware sales model, bolstered by international orders including a 108-qubit system sale to India's C-DAC.
The financial profile remains deeply pre-profit, with a trailing twelve-month operating loss exceeding $90 million and a GAAP net loss of $216 million (though significantly inflated by non-cash items). However, the balance sheet is a notable strength: $569 million in cash and investments with zero debt provides a multi-year runway without immediate dilution risk. The company's 2026 revenue guidance of $20-25 million, if achieved, would represent approximately 3x growth over FY2025's $7.1 million — an ambitious but not unreasonable target given Q1's outperformance.
Rigetti's quantum roadmap is both its greatest catalyst and risk factor. The 108-qubit Cepheus system is now generally available, with a 150+ qubit system targeted by year-end 2026 and an ambitious 1,000+ qubit system by end of 2027. The recent letter of intent for up to $100 million in U.S. Department of Commerce funding provides significant validation and financial support. However, the company's exclusion from DARPA's QBI Stage B program raises questions about its competitive standing versus peers like IonQ, IBM, and Google's quantum division.
At an $8.78 billion market cap on ~$10 million TTM revenue, RGTI trades at an extraordinary 848x price-to-sales ratio — pricing in a quantum computing future that remains years from commercial reality. The stock's 52-week range of $10.30 to $58.15 underscores extreme volatility typical of frontier technology plays. Investors must weigh the transformative potential of quantum computing against the reality that meaningful enterprise revenue likely remains 3-5 years away, with execution risk, competitive pressure, and potential dilution as persistent headwinds.
| Company | P/S (Trailing) | EV/Rev (Est.) | Rev Growth (YoY) | Cash Position | Market Cap |
|---|---|---|---|---|---|
| Rigetti Computing | ~545x | ~210x (Fwd) | +199% (Q1'26) | $569.0M | $8.6B |
| IonQ | ~97x | ~82x (Fwd) | +755% (Q1'26) | $162.4M | $23.7B |
| D-Wave Quantum | ~276x | ~159x (Fwd) | +68% (FY'26 est.) | $588.4M | $5.3-7.5B |
| IBM (Quantum) | ~3.5x | ~3.4x | +1% (Total Rev) | $13.7B | $260B+ |
| Scenario | Price Target | Assumptions | Probability |
|---|---|---|---|
| Quantum Breakthrough Acceleration | $55 | 1,000+ qubit system delivered on schedule by end of 2027 — Major enterprise contracts secured — Government CHIPS-adjacent funding fully realized — $100M+ annual revenue run-rate by FY2028 — Quantum advantage demonstrated in commercial use cases | 20% |
| Steady Roadmap Execution | $30 | 150+ qubit system delivered by end of 2026 — Revenue grows to $20-25M in FY2026 per guidance — Cash runway extends through 2028 without dilutive raise — Quantum computing market grows as expected — Competitive position maintained among top 5 players | 40% |
| Execution Delays & Dilution Risk | $8 | Qubit scaling milestones missed or delayed — DARPA exclusion signals technology gap vs. competitors — Cash burn accelerates requiring significant dilutive equity raise — Quantum computing commercialization timeline extends to 2030+ — IonQ, IBM, or Google capture dominant market share | 40% |